Key result
Higher TyG-WHtR linked to ~47% greater cardiovascular mortality risk in obese patients with MASLD.
Why the study?
Do the triglyceride-glucose (TyG) index and its obesity-related derivatives predict all-cause and cardiovascular mortality in adults with obesity and MASLD?
Cohort (n=4,807)
Do the triglyceride-glucose (TyG) index and its obesity-related derivatives predict all-cause and cardiovascular mortality in adults with obesity and MASLD?
Answers are grounded in this paper and cite their sources.
TyG-WHtR is a strong, time-dependent predictor of all-cause and cardiovascular mortality in patients with obesity and MASLD, and its integration into machine learning models enhances risk identification.
OBJECTIVE To investigate comorbid correlation and prognostic value of triglyceride-glucose (TyG) and its obesity-related derivatives for all-cause and cardiovascular mortality in the obesity with metabolic dysfunction-associated fatty liver disease (MASLD), and develop incremental predictive model using machine learning and SHapley Additive exPlanations (SHAP) analysis. METHODS 4807 adults with obesity and MASLD enrolled from National Health and Nutrition Examination Survey 1999-2018. Kaplan-Meier, Cox regression, and restricted cubic splines (RCS) were used to examine associations. Machine learning and incremental prognostic model were developed to predict mortality, with SHAP interpreting feature importance. RESULTS Both TyG and TyG-WHtR were associated with all-cause mortality after full adjustment, whereas TyG-WHtR showed a more robust association with cardiovascular mortality. TyG-WHtR showed the strongest association: each 1-unit increase linked to 31.7% and 46.7% higher risk of all-cause and cardiovascular mortality respectively in the fully adjusted model, with RCS showing an S-shaped relationship. Time-varying hazard ratio patterns suggested that the associations of TyG and TyG-WHtR with mortality were stronger in the early follow-up period and attenuated over time. XGBoost performed best with SHAP analysis identified age, fasting plasma glucose (FPG), male as primary factors. The incorporation of TyG and TyG-WHtR into predictive models modestly improved the prediction performance for mortality outcomes. CONCLUSIONS TyG-WHtR showed a stronger time-dependent association with mortality in obesity-MASLD comorbidity, while TyG mainly associated with all-cause mortality. S-shaped curve for TyG-WHtR indicates the critical need for early intervention. Integrating TyG-WHtR into XGBoost prognostic models enhances risk identification, while SHAP values clarify age, FPG, male as key drivers.
No takes yet. Share an insight, caveat, or question.
Nie et al. (2026) conducted a cohort in Obesity with metabolic dysfunction-associated fatty liver disease (MASLD) (n=4,807). Triglyceride-glucose (TyG) and TyG-WHtR was evaluated on All-cause and cardiovascular mortality (31.7% and 46.7% higher risk per 1-unit increase). Each 1-unit increase in TyG-WHtR was associated with a 31.7% and 46.7% higher risk of all-cause and cardiovascular mortality, respectively, in adults with obesity and MASLD.
Synapse has enriched 10 related papers. Consider them for comparative context: